TSC2 and Angiofibromas: The authors did not observe a difference in the number of angiofibromas, which could be due to the low number of patients with a TSC1 mutation, although there appears to be a trend of increasing numbers of angiofibromas in the presence of a TSC2 gene mutation (Fig. 4A).